Akebia Therapeutics(DE:AX9)
€0.37+0.00 (+0.83%)
DE:AX9
Akebia Therapeutics earnings date
€0.37
At close:+0.00 (+0.83%)
Akebia Therapeutics (AX9) Q2 2022 Earnings Report
2 Followers
DE:AX9 Q2 2022 EPS Results
- Actual EPS
- EUR 0.14
- Consensus EPS
- -EUR 0.29
- Beat/Miss
- Beat by +EUR 0.43
- One Year Ago EPS
- -EUR 0.46
DE:AX9 Q2 2022 Revenue Results
- Actual Revenue
- EUR 115.00M
- Expected Revenue
- EUR 48.11M
- Beat/Miss
- Beat by +EUR 66.89M
- YoY Revenue Growth
- +139.56%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/04/2022
- Time
- After Close
- Conference Call
- Thursday, August 4, 2022
DE:AX9 Upcoming Earnings
Akebia Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AX9 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.06- | -0.05 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.03-0.05 | 0 | ― | |
| Aug 05, 2026 | 2026 (Q2) | -0.04-0.03 | 0 | ― | |
| May 07, 2026 | 2026 (Q1) | -0.03-0.03 | 0.03 | -200.00% (-0.05) | |
| Feb 26, 2026 | 2025 (Q4) | -0.03-0.05 | -0.09 | 50.00% (+0.05) | |
| Nov 10, 2025 | 2025 (Q3) | -0.010.00 | -0.09 | 100.00% (+0.09) | |
| Aug 07, 2025 | 2025 (Q2) | -0.010.00 | -0.04 | 100.00% (+0.04) | |
| May 08, 2025 | 2025 (Q1) | -0.030.03 | -0.08 | 133.33% (+0.11) | |
| Mar 13, 2025 | 2024 (Q4) | -0.07-0.09 | 0 | ― | |
| Nov 07, 2024 | 2024 (Q3) | -0.06-0.09 | -0.07 | -25.00% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

